THIOREDOXIN AND THIOREDOXIN REDUCTASE IN THE PATHOGENESIS OF SELECTED HUMAN DISEASES, PART II

被引:0
作者
Popielarski, Marcin [1 ]
Ponamarczuk, Halszka [1 ]
Kusinska, Katarzyna [1 ]
Swiatkowska, Maria [1 ]
机构
[1] Uniwersytet Med & Lodzi, Zaklad Cytobiol & Prote, Katedra Nauk Biomed, Ul Mazowiecka 6-8, PL-92215 Lodz, Poland
关键词
thioredoxin; thioredoxin reductase; cancers; oxidative stress; apoptosis; CANCER-CELL-GROWTH; 1-METHYLPROPYL 2-IMIDAZOLYL DISULFIDE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MITOCHONDRIAL COMPLEX-III; MAMMALIAN THIOREDOXIN; ARSENIC TRIOXIDE; ORGANOTELLURIUM COMPOUNDS; MOTEXAFIN GADOLINIUM; MOLECULAR-MECHANISMS; GOLD(I) COMPLEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Thioredoxin and thioredoxin reductase form a thioredoxin system, which is involved in protecting cells against oxidative stress, regulation of apoptosis and regulation of tumorigenesis. Defects in thioredoxin system are associated with the pathogenesis of many human diseases, including the development of cancer. Overexpression of thioredoxin and thioredoxin reductase leads to increased proliferation, angiogenesis and initiation of anti-apoptotic pathways. Increased levels of thioredoxin and thioredoxin reductase are considered to be one of the mechanisms correlated with drug resistance in malignant cells. We can observe growing evidences suggesting the role of thioredoxin and thioredoxin reductase inhibitors in treatment of tumors. Results of therapy using thioredoxin and thioredoxin reductase inhibitors seems to be very promising.
引用
收藏
页码:159 / 179
页数:21
相关论文
共 50 条
  • [21] Thioredoxin reductase inhibitors: a patent review
    Zhang, Baoxin
    Zhang, Junmin
    Peng, Shoujiao
    Liu, Ruijuan
    Li, Xinming
    Hou, Yanan
    Han, Xiao
    Fang, Jianguo
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (05) : 547 - 556
  • [22] The Human Thioredoxin System: Modifications and Clinical Applications
    Hashemy, Seyed Isaac
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2011, 14 (03) : 191 - 204
  • [23] CLONING AND SEQUENCING OF A HUMAN THIOREDOXIN REDUCTASE
    GASDASKA, PY
    GASDASKA, JR
    COCHRAN, S
    POWIS, G
    FEBS LETTERS, 1995, 373 (01): : 5 - 9
  • [24] Thioredoxin Reductase and its Inhibitors
    Saccoccia, Fulvio
    Angelucci, Francesco
    Boumis, Giovanna
    Carotti, Daniela
    Desiato, Gianni
    Miele, Adriana E.
    Bellelli, Andrea
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2014, 15 (06) : 621 - 646
  • [25] Metal- and Semimetal-Containing Inhibitors of Thioredoxin Reductase as Anticancer Agents
    Gandin, Valentina
    Fernandes, Aristi P.
    MOLECULES, 2015, 20 (07) : 12732 - 12756
  • [26] Inactivation of thioredoxin reductase by acrolein
    Park, YS
    Fujiwara, N
    Koh, YH
    Takahashi, M
    Miyamoto, Y
    Suzuki, K
    Taniguchi, N
    MAILLARD REACTION IN FOOD CHEMISTRY AND MEDICAL SCIENCE: UPDATE FOR THE POSTGENOMIC ERA, 2002, 1245 : 433 - 434
  • [27] THIOREDOXIN-THIOREDOXIN REDUCTASE SYSTEM - A NOVEL TARGET FOR ANTITUMOR THERAPY
    Szokalska, Angelika
    POSTEPY BIOLOGII KOMORKI, 2008, 35 (03) : 391 - 402
  • [28] Isolation and characterization of thioredoxin and NADPH-dependent thioredoxin reductase from tomato (Solanum lycopersicum)
    Dai, Changbo
    Wang, Myeong-Hyeon
    BMB REPORTS, 2011, 44 (10) : 692 - 697
  • [29] Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia
    Berggren, M
    Gallegos, A
    Gasdaska, JR
    Gasdaska, PY
    Warneke, J
    Powis, G
    ANTICANCER RESEARCH, 1996, 16 (6B) : 3459 - 3466
  • [30] THE THIOREDOXIN THIOREDOXIN REDUCTASE REDOX SYSTEM AND CONTROL OF CELL-GROWTH
    POWIS, G
    OBLONG, JE
    GASDASKA, PY
    BERGGREN, M
    HILL, SR
    KIRKPATRICK, DL
    ONCOLOGY RESEARCH, 1994, 6 (10-11) : 539 - 544